Chemomab Therapeutics Ltd. (CMMB)
2.59
-0.10
(-3.72%)
USD |
NASDAQ |
Sep 10, 16:00
2.59
0.00 (0.00%)
After-Hours: 20:00
Chemomab Therapeutics Total Assets (Quarterly) : 10.24M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 10.24M |
| March 31, 2026 | 11.81M |
| December 31, 2025 | 13.81M |
| September 30, 2025 | 12.37M |
| June 30, 2025 | 11.13M |
| March 31, 2025 | 12.82M |
| December 31, 2024 | 16.96M |
| September 30, 2024 | 20.90M |
| June 30, 2024 | 14.54M |
| March 31, 2024 | 18.01M |
| December 31, 2023 | 22.15M |
| September 30, 2023 | 23.42M |
| June 30, 2023 | 28.85M |
| March 31, 2023 | 35.01M |
| December 31, 2022 | 43.06M |
| September 30, 2022 | 50.22M |
| June 30, 2022 | 56.38M |
| March 31, 2022 | 60.96M |
| December 31, 2021 | 64.35M |
| September 30, 2021 | 67.44M |
| June 30, 2021 | 70.52M |
| March 31, 2021 | 60.12M |
| December 31, 2020 | 6.179M |
| September 30, 2020 | 7.689M |
| June 30, 2020 | 10.02M |
| Date | Value |
|---|---|
| March 31, 2020 | 15.18M |
| December 31, 2019 | 19.76M |
| September 30, 2019 | 30.86M |
| June 30, 2019 | 31.06M |
| March 31, 2019 | 36.78M |
| December 31, 2018 | 12.57M |
| September 30, 2018 | 15.20M |
| June 30, 2018 | 21.32M |
| March 31, 2018 | 1.737M |
| December 31, 2017 | 2.087M |
| September 30, 2017 | 4.002M |
| June 30, 2017 | 5.645M |
| March 31, 2017 | 4.488M |
| December 31, 2016 | 5.649M |
| September 30, 2016 | 6.034M |
| June 30, 2016 | 2.085M |
| March 31, 2016 | 2.352M |
| December 31, 2015 | 3.516M |
| September 30, 2015 | 4.839M |
| June 30, 2015 | 6.034M |
| March 31, 2015 | 8.236M |
| December 31, 2014 | 6.204M |
| September 30, 2014 | 8.894M |
| June 30, 2014 | 3.386M |
| March 31, 2014 | 4.602M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| BioLineRx Ltd. | 33.48M |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 383.16M |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | 18.28M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.553M |
| Shareholders Equity (Quarterly) | 8.685M |
| Current Ratio | 6.411 |
| Net Debt Paydown Yield | 0.50% |